Quintiles

Novella Clinical selected by Scioderm to manage rare disease study

Thursday, October 17, 2013 09:01 AM

CRO Novella Clinical, a Quintiles company, has been selected by Scioderm, is a privately held, clinical-stage pharmaceutical company, to manage a phase IIb trial for the treatment of Epidermolysis Bullosa (EB), a rare genetic connective tissue condition. The trial will evaluate Scioderm’s investigational topical product, SD-101, for the treatment of skin blistering and erosions associated with this disease, including facilitation of healing of skin lesions and reduction of the incidence and/or severity of new lesions.

More... »

Quest Diagnostics

Novartis and Quintiles win SCRS 2013 Eagle Awards

Wednesday, October 16, 2013 09:05 AM

The Society for Clinical Research Sites (SCRS), a trade organization representing global clinical research sites, has announced the winners of its 2013 SCRS Eagle Awards. Novartis is this year's winning sponsor; Quintiles is the winning CRO.

More... »


Quintiles undertakes genomic “pre-profiling” feasibility study

Friday, September 27, 2013 10:22 AM

CRO Quintiles has announced plans to improve the development of biomarker-targeted therapies through a novel approach that promotes the genomic “pre-profiling” of cancer patients. Quintiles is undertaking a study with the participation of U.S. Oncology Research, supported by McKesson Specialty Health and The U.S. Oncology Network, to explore the operational feasibility and clinical benefits of an upfront approach to the genomic profiling of tumors from metastatic colorectal cancer (mCRC) patients. The study will investigate how pre-profiling and genomic sequencing data may support physician treatment decisions, including the identification of appropriate clinical trials for patients.

More... »

Quintiles closes Novella Clinical acquisition

Monday, September 23, 2013 01:40 PM

Global CRO Quintiles has completed its previously announced acquisition of Novella Clinical, a full-service CRO focused primarily on emerging oncology as well as medical devices and diagnostics.

More... »

Quintiles receives Computerworld Data+ Editor's Choice Award

Thursday, August 29, 2013 01:00 PM

CRO Quintiles has been recognized for its pioneering work creating big data solutions that help pharmaceutical organizations improve their probability of success throughout the drug development process, with a Computerworld Data+ Editor's Choice Award for its Quintiles Infosario platform.

More... »

Quintiles to acquire Novella Clinical

Wednesday, August 14, 2013 01:22 PM

CRO Quintileshas signed an agreement to acquire Novella Clinical, a full-service CRO focused primarily on emerging oncology customers as well as those in the medical device and diagnostics sectors. 

More... »

inVentiv Health Clinical expands executive team

Friday, August 9, 2013 02:02 PM

CRO inVentiv Health Clinical has appointed Dawn Anderson president of phase II-IV development, Martin Birkhofer chief medical officer and Richard Shimota chief financial officer.

More... »

Ascendancy Healthcare, Quintiles collaborate in China

Monday, July 29, 2013 01:30 PM

Ascendancy Healthcare, dedicated to the commercialization of therapeutic products to meet unmet medical needs in China and other high-growth Asian markets, has announced a multi-year collaboration with Quintiles, a provider of biopharmaceutical development and commercial outsourcing services.

More... »

Quintiles Infosario wins Informatica Innovation Award

Monday, June 10, 2013 11:44 AM

Quintiles received the 2013 Informatica Innovation Award for “Enterprise Data Integration” through the Quintiles Infosario solution, to integrate and master both clinical research and healthcare data across numerous institutions and at a scale never before accomplished in the biopharmaceutical industry.

More... »

Quintiles completes IPO of 27,236,841 shares of common stock

Wednesday, May 15, 2013 09:18 AM

Quintiles completed its initial public offering of 27,236,841 shares of its common stock at a price to the public of $40.00 per share.

More... »


CWWeekly

May 26

inVentiv Health aims to help sponsors prepare for new E.U. regulations on observational studies

ACRP partners with CRO Analytics to measure investigative sites' views of clinical trial quality

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs